Cambridge Epigenetix
Cambridge, United Kingdom
biomodal is a biotechnology company specializing in multiomics solutions that capture genetic and epigenetic information simultaneously. Their technology enables 6-base genome analysis from low-input DNA samples within a single workflow. Key products include the duet multiomics solution and modality XPLR. The platform supports applications in cancer research, neurodegenerative disease, ageing, and liquid biopsy. By integrating multiple modes of biology, biomodal provides transformative insights into health and disease for researchers and healthcare professionals, facilitating diagnostic and therapy development through advanced genomic sequencing and software tools.
Company Info
- Founded
- 2012
- Website
- www.cambridge-epigenetix.com
Only accessible to MedStartr community members.
Join nowWhat do you think of Cambridge Epigenetix?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.